Capital Markets Archives | Microdose Psychedelic Insights

February 23, 2021

A New Path To Wealth: Navigating The Psychedelic Investment Landscape

by Microdose Psychedelic Insights

February 23, 2021

February’s Psychedelic Capital Investigates Institutional Vs Retail Investor Impact

by Microdose Psychedelic Insights

February 12, 2021

Why The Future of The Psychedelic Industry Could Be In The Hands of Retail Investors

by Gaurav Dubey

February 5, 2021

The Reddit Revolution Riles up Retail Investors: How Short Selling Gamestop (GME) Will Impact the Psychedelic Market

by Microdose Psychedelic Insights

February 5, 2021

The Critical Role of Patents in Novel Drug Development

by Microdose Psychedelic Insights

January 30, 2021

In Another Historic First for Psychedelics, The World’s First Psychedelic ETF Has Launched

by Microdose Psychedelic Insights

January 22, 2021

SALT Talks: Psychedelics with Sa’ad Shah (Noetic Fund) & JR Rahn (MindMed)

by Tyler Bryden

January 18, 2021

Psychedelic Capital Returns in 2021: January’s Event Will Explore the First Raise & Life in Public Markets

by Microdose Psychedelic Insights

January 18, 2021

Cybin Announces CDN$20 Million Bought Deal Offering With Canaccord

by Microdose Psychedelic Insights

January 11, 2021

MindMed Closes C$92.1 Million Bought Deal Financing Agreement

by Microdose Psychedelic Insights